Pharmacotherapy of Diabetes Focused on Stroke
Journal of the Korean Neurological Association
;
: 235-250, 2019.
Article
in Korean
| WPRIM
| ID: wpr-766799
ABSTRACT
Cardiovascular disease, including stroke, is one of the major causes of death in diabetes. Numerous studies have long suggested reducing macrovascular complication such as ischemic vascular disease through intensive glycemic control, but none was successful proving the effect of glycemic control. Recently, new possibilities in cardiovascular disease reduction have been proposed through cardiovascular safety trials of newly developed anti-hyperglycemic agents. The purpose of this review is to introduce the traditional and newly developed anti-diabetic medications and review their effects regarding cardiovascular outcomes mainly focusing on stroke.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Vascular Diseases
/
Cardiovascular Diseases
/
Cause of Death
/
Stroke
/
Diabetes Complications
/
Diabetes Mellitus
/
Drug Therapy
/
Hypoglycemic Agents
Language:
Korean
Journal:
Journal of the Korean Neurological Association
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS